Biomarker Strategies LLC

UEI
MMRCBR1M7WN5
CAGE
4UPX8
Primary NAICS
621511 Medical Laboratories
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Website
biomarkerstrategies.com
Founded
2007
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Biomarker Strategies LLC's 4 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Sbir topic 354: a novel predictive test for response to combination immunotherapies for patients with non-small cell… Contract · 75N91019C00022 National Cancer Institute $1,345,018
Development of a companion diagnostic to predict response to cetuximab in patients with head and neck squamous cell… Grant · R43CA224512 National Cancer Institute $299,444
Sbir phase i topic 354-a novel predictive test for response to immunotherapies for patients with non-small cell lung… Contract · HHSN261201600006C National Cancer Institute $223,063
Pathmap nsclc: a functional companion diagnostic test to predict optimal therapy for patients with non-small cell lung… Grant · R44CA203068 National Cancer Institute $2,281,552

Quick answers

What is Biomarker Strategies LLC's UEI?

Biomarker Strategies LLC's Unique Entity ID (UEI) in SAM.gov is MMRCBR1M7WN5.

What is Biomarker Strategies LLC's CAGE code?

Biomarker Strategies LLC's CAGE code is 4UPX8.

What is Biomarker Strategies LLC's primary NAICS code?

Biomarker Strategies LLC's primary NAICS code is 621511 (Medical Laboratories).

Is Biomarker Strategies LLC registered in SAM.gov?

Biomarker Strategies LLC's SAM.gov registration expired on January 26, 2024.

What is Biomarker Strategies LLC's most recent federal award?

Biomarker Strategies LLC's most recent federal contract award is Sbir topic 354: a novel predictive test for response to combination immunotherapies for patients with non-small cell… (75N91019C00022), from National Cancer Institute, on September 16, 2019.

On GovTribe

See Biomarker Strategies LLC's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login